Wake up daily to our latest coverage of business done better, directly in your inbox.
Get your weekly dose of analysis on rising corporate activism.
The best of solutions journalism in the sustainability space, published monthly.
Select Newsletter
By signing up you agree to our privacy policy. You can opt out anytime.
Novartis’s eye care division Alcon has entered into an agreement with a division of Google Inc. to in-license its “smart lens” technology for ocular medical uses.
The agreement with Google[x] - a team within Google that is devoted to finding new solutions to big global problems - provides Alcon with the opportunity to develop and commercialize Google’s “smart lens” technology which it says gives it the potential to transform eye care.
?“We are looking forward to working with Google to bring together their advanced technology and our extensive knowledge of biology to meet unmet medical needs,” said Novartis ceo Joseph Jimenez. “This is a key step for us to go beyond the confines of traditional disease management, starting with the eye.” ? ?
“Our dream is to use the latest technology in the miniaturization of electronics to help improve the quality of life for millions of people,” said Sergey Brin, co-founder, Google. “We are very excited to work with Novartis to make this dream come true."? ?
The transaction remains subject to anti-trust approvals.? ?
TriplePundit has published articles from over 1000 contributors. If you'd like to be a guest author, please get in touch!
